IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.282
EU - Europa 7.964
AS - Asia 4.670
SA - Sud America 877
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 99
OC - Oceania 16
Totale 32.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.095
RU - Federazione Russa 2.458
CN - Cina 1.803
UA - Ucraina 1.531
SG - Singapore 1.209
VN - Vietnam 1.095
IT - Italia 892
GB - Regno Unito 763
BR - Brasile 690
SE - Svezia 674
DE - Germania 644
FR - Francia 525
FI - Finlandia 150
HK - Hong Kong 135
NL - Olanda 86
BD - Bangladesh 74
CA - Canada 71
AR - Argentina 64
IN - India 59
PL - Polonia 52
MX - Messico 46
JP - Giappone 44
IQ - Iraq 42
EU - Europa 39
ZA - Sudafrica 31
EC - Ecuador 30
IE - Irlanda 30
ID - Indonesia 25
PK - Pakistan 24
ES - Italia 23
BE - Belgio 22
SA - Arabia Saudita 19
AT - Austria 18
CL - Cile 18
CO - Colombia 18
MA - Marocco 18
MY - Malesia 18
TR - Turchia 18
VE - Venezuela 18
CR - Costa Rica 17
PY - Paraguay 16
LV - Lettonia 15
JM - Giamaica 14
AU - Australia 12
AZ - Azerbaigian 12
TN - Tunisia 12
UZ - Uzbekistan 11
KE - Kenya 10
HN - Honduras 9
BO - Bolivia 8
UY - Uruguay 8
BG - Bulgaria 7
ET - Etiopia 7
GR - Grecia 7
JO - Giordania 7
KR - Corea 7
CZ - Repubblica Ceca 6
DK - Danimarca 6
DZ - Algeria 6
GT - Guatemala 6
KZ - Kazakistan 6
LU - Lussemburgo 6
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
IR - Iran 5
LB - Libano 5
PA - Panama 5
PE - Perù 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
AL - Albania 4
BH - Bahrain 4
EG - Egitto 4
LT - Lituania 4
NI - Nicaragua 4
OM - Oman 4
EE - Estonia 3
HR - Croazia 3
IL - Israele 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
Totale 31.916
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.681
Ann Arbor 1.318
Ashburn 1.172
Dallas 1.108
Wilmington 1.058
Chandler 897
Seattle 842
Dong Ket 774
San Jose 734
Cambridge 694
Dearborn 535
Singapore 453
Nyköping 441
Jacksonville 429
Shenzhen 397
Southend 392
Moscow 381
Beijing 337
Boardman 286
Council Bluffs 181
Princeton 159
Lawrence 153
Hong Kong 127
The Dalles 127
Ho Chi Minh City 114
New York 109
Ogden 108
Shanghai 108
Naples 107
Phoenix 95
Santa Clara 90
Los Angeles 80
Hanoi 76
San Diego 76
Grafing 69
Englewood 63
Norwalk 63
Düsseldorf 62
Rome 61
London 55
Des Moines 52
Groningen 49
Chicago 48
São Paulo 47
Milan 44
Yubileyny 44
Munich 43
Falls Church 39
Nanjing 36
Kraków 34
Columbus 31
Jinan 31
Agrolândia 29
Dublin 29
Tokyo 27
Rio de Janeiro 25
Bergamo 22
Shenyang 22
Helsinki 21
Hefei 19
Nanchang 19
Napoli 19
Amsterdam 18
Brussels 18
Frankfurt am Main 18
Toledo 18
Edinburgh 17
Mexico City 17
Washington 17
Montreal 16
Auburn Hills 15
Baghdad 15
Guayaquil 15
Redwood City 15
Riga 15
Surprise 15
Warsaw 15
Boston 14
Brasília 14
Bremen 14
Haiphong 14
Kunming 14
Belo Horizonte 13
Changsha 13
Curitiba 13
Da Nang 13
Florence 13
Salt Lake City 13
Toronto 13
Atlanta 12
Brooklyn 12
Kilburn 12
Miami 12
Orem 12
Vienna 12
Baku 11
Catania 11
Guangzhou 11
Totale 21.241
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 663
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 346
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 328
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 326
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 317
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 306
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 294
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 291
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 288
Abnormal eating behaviors in progressive supranuclear palsy 285
Cognitive and affective theory of mind in patients with essential tremor 283
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 273
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 270
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 267
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 265
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 262
Affective theory of mind in patients with Parkinson's disease: comment 260
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 259
Impact of cognitive tasks on kinematic gait parameters in FTD patients 258
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 257
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 257
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 256
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 255
Apoptotic mechanisms in mutant LRRK2-mediated cell death 253
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 252
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 247
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 245
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 243
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 243
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 241
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 241
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 240
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 236
Pathological gambling in Parkinson's disease. A comprehensive review 234
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 234
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 234
The "eye of the tiger" sign in pure akinesia with gait freezing 229
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 229
Gender and non motor fluctuations in Parkinson's disease: A prospective study 229
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 227
Gender and non motor fluctuations in Parkinson's disease: a prospective study 226
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 225
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 224
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 223
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 223
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 223
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 221
How does smoking affect olfaction in Parkinson's disease? 221
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 221
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 220
A (single case) rehabilitation program based on cueing for freezing of speech 219
Electrophysiological comparison between males and females in HNPP 218
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 218
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 217
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 217
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 216
Season of birth and Parkinson's disease: possible relationship? 215
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 214
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 213
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 211
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 210
Normative data for the Montreal Cognitive Assessment in an Italian population sample 210
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 210
Early MRI findings in Acquired hepatocerebral degeneration 208
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 208
Uric acid relates to dopamine transporter availability in Parkinson's disease 207
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 206
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 205
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 204
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 204
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 204
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 203
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 202
The closing-in phenomenon in Parkinson's disease 202
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 202
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 201
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 200
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 199
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 198
Linkage exclusion in Italian families with hereditary essential tremor 196
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 196
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 196
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 196
The relationship between cerebral vascular disease and parkinsonism: the VADO study 196
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 195
Hemi-Restless Legs Syndrome induced by Clebopride 192
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 191
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 189
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 189
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 189
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 188
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 187
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 187
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease 187
Using gait analysis' parameters to classify Parkinsonism: A data mining approach 186
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 184
Reply to Zappia et al.'s comment on personality and Parkinson's Disease: A meta-analysis 183
Neuropsychological correlates of theory of mind in nondemented patients with early Parkinson’s Disease 182
Quitting smoking: an early non-motor feature of Parkinson's disease? 182
Cognitive correlates of “pure apathy” in Parkinson's disease 182
Totale 23.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.144 0 0 0 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.479 61 360 26 109 96 401 1.121 1.358 336 238 206 167
2025/20265.459 377 863 793 480 224 112 540 524 623 577 186 160
2026/20271.176 112 226 423 415 0 0 0 0 0 0 0 0
Totale 32.240